| Item Type | Name |
|
Concept
|
Fatty Liver, Alcoholic
|
|
Concept
|
Fatty Liver
|
|
Concept
|
Liver Cirrhosis, Experimental
|
|
Concept
|
Liver Neoplasms
|
|
Concept
|
Liver Circulation
|
|
Concept
|
Liver Cirrhosis, Alcoholic
|
|
Concept
|
Liver Diseases, Alcoholic
|
|
Concept
|
Liver Function Tests
|
|
Concept
|
Liver
|
|
Concept
|
Liver Cirrhosis
|
|
Concept
|
Liver Regeneration
|
|
Concept
|
Liver Transplantation
|
|
Concept
|
Mitochondria, Liver
|
|
Concept
|
Liver Failure
|
|
Concept
|
End Stage Liver Disease
|
|
Concept
|
Chemical and Drug Induced Liver Injury
|
|
Concept
|
Liver Diseases
|
|
Academic Article
|
TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis.
|
|
Academic Article
|
Recurrent autoimmune hepatitis after orthotopic liver transplantation.
|
|
Academic Article
|
Apolipoprotein synthesis in nonalcoholic steatohepatitis.
|
|
Academic Article
|
Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation.
|
|
Academic Article
|
Protein metabolism and liver disease.
|
|
Academic Article
|
Hepatitis G virus infection in patients transplanted for cryptogenic cirrhosis: red flag or red herring?
|
|
Academic Article
|
Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation.
|
|
Academic Article
|
The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
|
|
Academic Article
|
Obesity, hyperlipidemia, and metabolic syndrome.
|
|
Academic Article
|
Natural history and management of hepatitis C infection after liver transplantation.
|
|
Academic Article
|
Fibrosing NASH: on being a blind man in a dark room looking for a black cat (that isn't there).
|
|
Academic Article
|
Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels.
|
|
Academic Article
|
A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C.
|
|
Academic Article
|
Recipient IL28B polymorphism is an important independent predictor of posttransplant diabetes mellitus in liver transplant patients with chronic hepatitis C.
|
|
Academic Article
|
Decreased muscle mass in nonalcoholic fatty liver disease: new evidence of a link between growth hormone and fatty liver disease?
|
|
Academic Article
|
Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation.
|
|
Academic Article
|
Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation.
|
|
Academic Article
|
Preserving flow in liver transplant recipients: mTOR inhibitors everolimus and sirolimus are not peas from a pod.
|
|
Academic Article
|
Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: a case-control study and literature review.
|
|
Academic Article
|
Response to Fibrosis progression in patients treated for hepatitis C recurrence.
|
|
Academic Article
|
Liver transplantation for cryptogenic cirrhosis.
|
|
Academic Article
|
Recurrent and new hepatitis C virus infection after liver transplantation.
|
|
Academic Article
|
Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease.
|
|
Academic Article
|
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease.
|
|
Academic Article
|
A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation.
|
|
Academic Article
|
Pre-emptive treatment of recurrent hepatitis C infection.
|
|
Academic Article
|
Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis.
|
|
Academic Article
|
Branched chains revisited.
|
|
Academic Article
|
Clinical significance of TT virus infection in patients with chronic hepatitis C.
|
|
Academic Article
|
Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
|
|
Academic Article
|
Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: a molecular and histologic study.
|
|
Academic Article
|
Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation.
|
|
Academic Article
|
Tissue-specific regulation of mitochondrial and cytoplasmic protein synthesis rates by insulin.
|
|
Academic Article
|
Mycophenolate and hepatitis C: salve on a wound or gasoline on a fire?
|
|
Academic Article
|
Hepatitis C infection in liver transplantation.
|
|
Academic Article
|
Branched-chain amino acid-enriched supplements as therapy for liver disease: Rasputin lives.
|
|
Academic Article
|
Retransplantation for HCV--the view through a broken crystal ball.
|
|
Academic Article
|
Predictors of patient and graft survival following liver transplantation for hepatitis C.
|
|
Academic Article
|
Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.
|
|
Academic Article
|
Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases.
|
|
Academic Article
|
The impact of advancing donor age on histologic recurrence of hepatitis C infection: the perils of ignored maternal advice.
|
|
Academic Article
|
Characterization of hepatitis B virus surface antigen and polymerase mutations in liver transplant recipients pre- and post-transplant.
|
|
Academic Article
|
Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation.
|
|
Academic Article
|
Management of recurrence of hepatitis C infection following liver transplantation.
|
|
Academic Article
|
Hepatotoxicity after desflurane anesthesia.
|
|
Academic Article
|
Origin of adenocarcinoma in a transplanted liver determined by microsatellite analysis.
|
|
Academic Article
|
Natural history of hepatitis C and outcomes following liver transplantation.
|
|
Academic Article
|
Long-term results and modeling to predict outcomes in recipients with HCV infection: results of the NIDDK liver transplantation database.
|
|
Academic Article
|
Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
|
|
Academic Article
|
Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease.
|
|
Academic Article
|
The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database.
|
|
Academic Article
|
A practical guide to the management of HCV infection following liver transplantation.
|
|
Academic Article
|
JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis.
|
|
Academic Article
|
Fetal obesity syndrome: maternal nutrition as a cause of nonalcoholic steatohepatitis.
|
|
Academic Article
|
Recurrence of primary sclerosing cholangitis following liver transplantation.
|
|
Academic Article
|
Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
|
|
Academic Article
|
Impact of nutritional status on outcomes after liver transplantation.
|
|
Academic Article
|
Insulin's effect on synthesis rates of liver proteins. A swine model comparing various precursors of protein synthesis.
|
|
Academic Article
|
Patient and graft survival following liver transplantation for hepatitis C: much ado about something.
|
|
Academic Article
|
Ultrasound-assisted percutaneous liver biopsy performed by a physician assistant.
|
|
Academic Article
|
Liver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus recurrence.
|
|
Academic Article
|
Obesity in potential living donors: success with simplicity.
|
|
Academic Article
|
Branched-chain amino-acid granules: can they improve survival in patients with liver cirrhosis?
|
|
Academic Article
|
Hepatocyte tails.
|
|
Academic Article
|
Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: results of a phase 2 randomized study.
|
|
Academic Article
|
Combined heart and liver transplantation: a single-center experience.
|
|
Academic Article
|
Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation.
|
|
Academic Article
|
Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study.
|
|
Academic Article
|
Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients.
|
|
Academic Article
|
Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease.
|
|
Academic Article
|
Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity.
|
|
Academic Article
|
Recurrence of hepatitis C infection: Where are we now?
|
|
Academic Article
|
Branched-chain amino acid enriched supplements as therapy for liver disease.
|
|
Academic Article
|
Perioperative viral kinetics: new insights or the Emperor's new clothes?
|
|
Academic Article
|
Approach to recurrent hepatitis C following liver transplantation.
|
|
Academic Article
|
Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients.
|
|
Academic Article
|
Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain?
|
|
Academic Article
|
Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection.
|
|
Academic Article
|
Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
|
|
Academic Article
|
A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA.
|
|
Academic Article
|
Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.
|
|
Academic Article
|
The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
|
|
Academic Article
|
Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database.
|
|
Academic Article
|
Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview.
|
|
Academic Article
|
Nutrition in alcoholic liver disease.
|
|
Academic Article
|
Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival.
|
|
Academic Article
|
Impact of obesity on treatment of chronic hepatitis C.
|
|
Academic Article
|
Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C.
|
|
Academic Article
|
Antibody-based immunosuppression following liver transplantation: the plot thickens.
|
|
Academic Article
|
Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis.
|
|
Academic Article
|
Hepatic gene networks in morbidly obese patients with nonalcoholic fatty liver disease.
|
|
Academic Article
|
Aquaporin-1 facilitates angiogenic invasion in the pathological neovasculature that accompanies cirrhosis.
|
|
Academic Article
|
NAFLD and insulin resistance do not increase the risk of postoperative complications among patients undergoing bariatric surgery--a prospective analysis.
|
|
Academic Article
|
Posttransplant metabolic syndrome: new evidence of an epidemic and recommendations for management.
|
|
Academic Article
|
Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis.
|
|
Academic Article
|
ChREBP in NASH - a liver transcription factor comes in from the cold.
|
|
Academic Article
|
The clinical significance of simultaneous infection with hepatitis G virus in patients with chronic hepatitis C.
|
|
Academic Article
|
Genotype 1b and severity of posttransplant recurrence of hepatitis C infection- unconvictable felon or wrongly accused?
|
|
Academic Article
|
Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy.
|
|
Academic Article
|
Fatty liver and liver transplantation.
|
|
Academic Article
|
Recurrence of hepatocellular carcinoma: importance of mRECIST response to chemoembolization and tumor size.
|
|
Academic Article
|
Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
|
|
Academic Article
|
Chronic kidney disease (CKD) and NAFLD: time for awareness and screening.
|
|
Academic Article
|
Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrence.
|
|
Academic Article
|
Lack of Survival Benefit Following Liver Transplantation With MELD Exception Points for Hepatocellular Carcinoma: Beyond the Unblinding of Lady Justice.
|
|
Academic Article
|
Obesity is independently associated with infection in hospitalised patients with end-stage liver disease.
|
|
Academic Article
|
Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study.
|
|
Academic Article
|
Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease.
|
|
Academic Article
|
Daclizumab induction therapy in liver transplant recipients with renal insufficiency.
|
|
Academic Article
|
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.
|
|
Academic Article
|
Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with histologically advanced NAFLD.
|
|
Academic Article
|
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.
|
|
Academic Article
|
Investigation of PNPLA3 and IL28B genotypes on diabetes and obesity after liver transplantation: insight into mechanisms of disease.
|
|
Academic Article
|
Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail.
|
|
Academic Article
|
Nonalcoholic steatohepatitis (NASH) does not increase complications after laparoscopic bariatric surgery.
|
|
Academic Article
|
The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
|
|
Academic Article
|
The lethal and enduring inequity of deceased donor liver allocation policy for hepatocellular carcinoma in the United States.
|
|
Academic Article
|
The impact of gender and NASH on chronic kidney disease before and after liver transplantation.
|
|
Academic Article
|
Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B.
|
|
Academic Article
|
Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation.
|
|
Academic Article
|
Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
|
|
Academic Article
|
Hypophosphatemia after right hepatectomy for living donor liver transplantation.
|
|
Academic Article
|
Nonalcoholic fatty liver disease: a review of current understanding and future impact.
|
|
Academic Article
|
Noninvasive indices of fibrosis in NAFLD: starting to think about a three-hit (at least) phenomenon.
|
|
Academic Article
|
Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection.
|
|
Academic Article
|
PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus.
|
|
Academic Article
|
Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: a proteomic signature validated by enzyme-linked immunosorbent assay.
|
|
Academic Article
|
Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: a systematic review and meta-analysis.
|
|
Academic Article
|
Evolving aspects of liver transplantation for nonalcoholic steatohepatitis.
|
|
Academic Article
|
How important is acute cellular rejection?
|
|
Academic Article
|
Victory and defeat at Heraclea - treating hepatitis C infection following liver transplantation with telaprevir and boceprevir.
|
|
Academic Article
|
Serum adipokine and inflammatory markers before and after liver transplantation in recipients with major cardiovascular events.
|
|
Academic Article
|
Metabolic syndrome and liver transplantation: a review and guide to management.
|
|
Academic Article
|
Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells.
|
|
Academic Article
|
Pretransplant serum troponin levels are highly predictive of patient and graft survival following liver transplantation.
|
|
Academic Article
|
The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables.
|
|
Academic Article
|
Interleukin-28B polymorphism in hepatitis C and liver transplantation.
|
|
Academic Article
|
Sirolimus as a calcineurin inhibitor- and renal-sparing agent: all good things come to those who wait versus spare the nephron, spoil the patient.
|
|
Academic Article
|
Improving long-term outcomes after liver transplantation.
|
|
Academic Article
|
Treatment of HCV prior to liver transplantation to prevent HCV recurrence - wise or wasteful?
|
|
Academic Article
|
Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis.
|
|
Academic Article
|
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.
|
|
Academic Article
|
Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free Regimen.
|
|
Academic Article
|
On-treatment HCV RNA in patients with varying degrees of fibrosis and cirrhosis in the SOLAR-1 trial.
|
|
Academic Article
|
Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management.
|
|
Academic Article
|
Nonalcoholic Fatty Liver Disease and Liver Transplantation.
|
|
Academic Article
|
Alcoholic Liver Disease and Liver Transplantation.
|
|
Academic Article
|
The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health.
|
|
Academic Article
|
Roadmap for improving patient and graft survival in the next 10 years.
|
|
Academic Article
|
Usefulness of Liver Transplantation in the Elderly: The Converging Impact of Risk and Benefit.
|
|
Academic Article
|
Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.
|
|
Academic Article
|
Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation.
|
|
Academic Article
|
Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation.
|
|
Academic Article
|
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.
|
|
Academic Article
|
Prevalence and clinical consequences of Hepatitis E in patients who underwent liver transplantation for chronic Hepatitis C in the United States.
|
|
Academic Article
|
Protecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.
|
|
Academic Article
|
Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
|
|
Academic Article
|
A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition.
|
|
Academic Article
|
International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT CANDIDATES.
|
|
Academic Article
|
International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT RECIPIENTS.
|
|
Academic Article
|
Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension.
|
|
Academic Article
|
Predictors of Cardiovascular Events After Liver Transplantation.
|
|
Academic Article
|
Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial.
|
|
Academic Article
|
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.
|
|
Academic Article
|
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients.
|
|
Academic Article
|
Everolimus Is Associated With Less Weight Gain Than Tacrolimus 2 Years After Liver Transplantation: Results of a Randomized Multicenter Study.
|
|
Academic Article
|
Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models.
|
|
Academic Article
|
Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
|
|
Academic Article
|
Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib.
|
|
Academic Article
|
Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.
|
|
Academic Article
|
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
|
|
Academic Article
|
Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis.
|
|
Academic Article
|
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial.
|
|
Academic Article
|
International Liver Transplantation Society Asian Consensus on the Management of Hepatitis C Virus Infection in Resource Limited Setting-From Noncirrhotic to Decompensated Disease and After Liver Transplantation.
|
|
Academic Article
|
DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis.
|
|
Academic Article
|
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease.
|
|
Academic Article
|
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
|
|
Academic Article
|
Liver Transplantation for Nonalcoholic Steatohepatitis: New Evidence of a Profound Increase Across Age Cohorts.
|
|
Academic Article
|
Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.
|
|
Academic Article
|
International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients.
|
|
Academic Article
|
FGF-19 agonism for NASH: a short study of a long disease.
|
|
Academic Article
|
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.
|
|
Academic Article
|
The Triumph of Bacchus: The Emergence of Nonalcoholic Steatohepatitis and Alcoholic Liver Disease as the Leading Causes of Mortality From Cirrhosis.
|
|
Academic Article
|
Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
|
|
Academic Article
|
Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era.
|
|
Academic Article
|
Liver Allocation Policies in the USA: Past, Present, and the Future.
|
|
Academic Article
|
New organ allocation policy in liver transplantation in the United States.
|
|
Academic Article
|
Abnormal liver tests after liver transplantation.
|
|
Academic Article
|
Simultaneous heart, liver and kidney transplantation: A viable option for heart failure patients with multiorgan failure.
|
|
Academic Article
|
Nonalcoholic Steatohepatitis After Liver Transplantation.
|
|
Academic Article
|
A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial.
|
|
Academic Article
|
Hepatotoxicity From Immune Checkpoint Inhibitors: A Systematic Review and Management Recommendation.
|
|
Academic Article
|
Nonalcoholic fatty liver disease: impact on healthcare resource utilization, liver transplantation and mortality in a large, integrated healthcare system.
|
|
Academic Article
|
Hiding in the Water.
|
|
Academic Article
|
Liver transplantation for alcoholic hepatitis in the United States: Excellent outcomes with profound temporal and geographic variation in frequency.
|
|
Academic Article
|
Simultaneous Heart-Liver Transplantation for Congenital Heart Disease in the United States: Rapidly Increasing With Acceptable Outcomes.
|
|
Academic Article
|
Liver Transplantation of HCV-viremic Donors Into HCV-negative Recipients in the United States: Increasing Frequency With Profound Geographic Variation.
|
|
Academic Article
|
Knockout of sulfatase 2 is associated with decreased steatohepatitis and fibrosis in a mouse model of nonalcoholic fatty liver disease.
|
|
Academic Article
|
En bloc liver and pancreas transplantation after total pancreatectomy with autologous islet transplantation.
|
|
Academic Article
|
Living Donor Liver Transplantation in the United States: Evolution of Frequency, Outcomes, Center Volumes, and Factors Associated With Outcomes.
|
|
Academic Article
|
"Raising HOPE": Improved Outcomes for HIV/HCV-coinfected Liver Transplant Recipients in the Direct-acting Antiviral Era.
|
|
Academic Article
|
Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials.
|
|
Academic Article
|
Safety, Pharmacokinetics, Pharmacodynamics, and Formulation of Liver-Distributed Farnesoid X-Receptor Agonist TERN-101 in Healthy Volunteers.
|
|
Academic Article
|
Mandatory Hepatology Education for Internal Medicine Residents: Long-Term Effects and Implications for Workforce Needs.
|
|
Academic Article
|
Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD.
|
|
Academic Article
|
The Practice of Retransplantation for Recurrent Alcohol-associated Liver Disease in the United States Is Uncommon With Acceptable Outcomes.
|
|
Academic Article
|
Preservation solutions for static cold storage in donation after circulatory death and donation after brain death liver transplantation in the United States.
|
|
Academic Article
|
Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, placebo-controlled MIRNA (Metabolic Interventions to Resolve NASH with fibrosis) study.
|
|
Academic Article
|
Relatively Poor Long-term Outcomes Following Liver Transplantation for NASH in the United States.
|
|
Academic Article
|
Imbalanced gut microbiota predicts and drives the progression of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in a fast-food diet mouse model.
|
|
Concept
|
Acute-On-Chronic Liver Failure
|
|
Concept
|
Non-alcoholic Fatty Liver Disease
|
|
Grant
|
REDUCTION OF HCV RECURRANCE AFTER LIVER TRANSPLANTATION
|
|
Grant
|
Pathophysiology and Characterisation of NAFLD
|
|
Academic Article
|
Liver Transplantation 2023: Status Report, Current and Future Challenges.
|
|
Academic Article
|
Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database.
|
|
Academic Article
|
Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance.
|
|
Academic Article
|
Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease.
|
|
Academic Article
|
Macrophage RAGE activation is proinflammatory in NASH.
|
|
Academic Article
|
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
|
|
Academic Article
|
Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting.
|